Lilly Asia & Lapam Co-lead to Treat Abnormal Heartbeats
03 Aug 2023
US$ 19.00
Lilly Asia Ventures and Lapam Capital co-led the Rmb200 million (US$28 million) series A funding round of EnChannel...
Tag
HealthTech
Related Publications
Listen to Japan/South Korea Funds (Subscribers' Weekly 09 Jan 2026)...
Subscribers’ Weekly for the week ending 9 Jan 2026...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.